Real-Time Polymerase Chain Reaction to Determine the Prevalence and Copy Number of Epstein-Barr Virus and Cytomegalovirus DNA in Subgingival Plaque at Individual Healthy and Periodontal Disease Sites
Department of Oral Health Practice, University of Kentucky, Lexington, KY, USA. Journal of Periodontology
(Impact Factor: 2.71).
08/2009; 80(7):1133-40. DOI: 10.1902/jop.2009.080644
Detection of cytomegalovirus (CMV) and Epstein-Barr virus (EBV) in plaque from patients with periodontal disease provides support for the theory that these viruses play a role in the pathogenesis of periodontitis. This study sought to further define this relationship by determining the prevalence of these viruses at individual disease and healthy sites of patients with periodontal disease and to determine whether the presence and amount of viral DNA correlate with disease severity.
Subgingival plaque from three healthy and three disease sites of 65 patients who had chronic periodontitis were evaluated for the presence and amount of EBV, CMV, and Fusobacterium nucleatum DNA using real-time polymerase chain reaction. Patient serum was evaluated for antibodies against EBV and CMV using enzyme-linked immunosorbent assays.
EBV DNA was detected in 18.5% of subgingival plaque samples (72/390) and in at least one of the six plaque samples in 44.6% (29/65) of the patients. CMV DNA was detected in one plaque sample (0.3%). EBV was significantly more prevalent in disease sites (28.2%; 55/195) than in healthy sites (8.7%; 17/195; P = 0.002). However, neither EBV prevalence nor its amount correlated with increased probing depth >5 mm or attachment loss >2 mm, whereas the amount of F. nucleatum DNA did. Sites positive for EBV had a median copy number of eight. Antibodies against EBV and CMV were detected in 85.7% and 78.6% of persons evaluated, respectively.
EBV was infrequent and CMV was rarely present in individual subgingival sites affected by chronic periodontitis.
Available from: Jamal M. Stein
- "Thereby, herpesviruses (in particular EBV and HCMV) might trigger disease progression in a local immunosuppressive manner or have direct cytopathic effects on fibroblasts and immunocompetent cells (Contreras & Slots 2000, Slots 2005, 2010). However, maintenance of this model is challenged by studies that could not confirm an increased prevalence of herpesviruses (EBV, HCMV) in chronic and aggressive periodontitis (Dawson et al. 2009, Nibali et al. 2009) or that could not find differences in the viral load between shallow and deep pockets (Konstantinidis et al. 2005). This inconsistency might be caused by methodological reasons: Most of the studies with positive associations were done with a small sample size (<30), limiting the degree to which these results can be generalized . "
[Show abstract] [Hide abstract]
Herpes simplex virus type 1 (HSV-1), human cytomegalovirus (HCMV) and Epstein-Barr virus (EBV) have been suspected to play a causal role in periodontitis pathogenesis. The aim of this study was to determine the prevalence of these viruses in subgingival plaque samples of Caucasian patients with generalized aggressive periodontitis compared to periodontally healthy controls.
A total of 65 patients with aggressive periodontitis and 65 unmatched controls from Germany were investigated in the study. Subgingival plaque samples were analysed for the presence of HSV-1, EBV and HCMV by quantitative real-time polymerase chain reaction assays. Viral antibody titres were determined quantitatively by immunosorbent assays.
DNA of HSV-1 and HCMV were detected in 1.5% of the patients and controls, whereas EBV DNA was present in 10.8% and 13.9% respectively. Detection rates of serum IgG against HSV-1 (76.1% versus 73.9%), EBV (98.5% versus 96.9%), HCMV (47.7% versus 46.2%) and IgM levels against HSV-1 (6.2% versus 1.5%), EBV (0% versus 0%), HCMV (0% versus 1.5%) did not significantly differ between patients and controls.
The data of our study do not suggest any contribution of HSV-1, EBV or HCMV to aggressive periodontitis in a German population. Ethnic and methodological aspects might have caused conflicting results of previous studies.
Journal Of Clinical Periodontology 09/2012; 40(1). DOI:10.1111/jcpe.12021 · 4.01 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: The aim of this study was to determine the presence and quantity of human cytomegalovirus (CMV) and Epstein-Barr virus (EBV) DNA in the saliva of patients with periodontitis, and investigate the correlation between these factors.
Presence and amounts of viral DNA in saliva and subgingival plaque samples, from healthy and disease sites, of 65 adults diagnosed with chronic periodontitis were determined using quantitative real-time polymerase chain reaction.
Epstein-Barr virus DNA was detected in saliva of 81.5% (53/65) of patients at a median concentration of 4325 copies ml(-1). CMV DNA was detected in saliva of one individual (1.5%) at low copy number. Patients who had EBV in saliva were 10 times more likely to have EBV in subgingival plaque than patients lacking EBV in saliva (odds ratio = 10.1, 95% confidence interval = 2.6-39.5; P = 0.0009). EBV DNA burden in saliva positively correlated with the amounts detected in plaque and with amounts detected in increasing number of affected sites (P < 0.0001). EBV DNA presence and quantity in saliva did not correlate with increasing severity of disease as measured by periodontal indices.
Epstein-Barr virus DNA presence and burden in saliva are associated with its presence and burden in subgingival plaque, but presence and burden in saliva does not correlate with periodontal disease severity.
Oral Diseases 07/2009; 15(8):554-9. DOI:10.1111/j.1601-0825.2009.01585.x · 2.43 Impact Factor
Available from: elmtreedental.com
Periodontology 2000 06/2010; 53(1):89-110. DOI:10.1111/j.1600-0757.2009.00325.x · 3.63 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.